Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Endocrinol Invest ; 44(6): 1209-1218, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32897534

RESUMEN

PURPOSE: Thyroid dysfunction in patients with cardiac disease is associated with worse outcomes. This study aimed to evaluate the prevalence and analyse predictors and outcomes of thyroid dysfunction in patients presenting with an acute myocardial infarction (AMI). METHODS: A prospective multicentre observational study of patients recruited from six acute hospitals within the North of England. Consecutive patients without previous thyroid disease presenting with both ST-elevation AMI (STEMI) and non-ST-elevation AMI (NSTEMI) were recruited to the Thyroxine in Acute Myocardial Infarction 1 (ThyrAMI-1) cohort study between December 2014 and 2016. Thyroid profile, standard biochemistry measurements and demographic information were obtained within 12 h of admission to hospital. Multivariable logistic regression analyses were performed to assess the predictors of thyroid dysfunction and Cox proportional hazards analyses were utilised to compare all-cause mortality by categories of thyroid dysfunction up to June 2019. RESULTS: Of the 1802 participants analysed, 1440 (79.9%) were euthyroid, 312 (17.3%) had subclinical hypothyroidism (SCH), 22 (1.2%) had subclinical hyperthyroidism (SHyper) and 25 (1.3%) had low T3 syndrome (LT3S). Predictors for SCH were increasing age, female sex, higher thyroid peroxidase antibody (TPOAb) levels, higher serum creatinine levels and early morning sampling time (between 00:01-06:00 h). The predictors of SHyper were lower body mass index and afternoon sampling time (between 12:01 and 18:00 h). Predictors of LT3S were increasing age, higher creatinine levels and presence of previous ischaemic heart disease. Compared to the euthyroid group, patients with LT3S had higher all-cause mortality; adjusted hazard ratio (95% CI) of 2.02 (1.03-3.95), p = 0.04, whereas those with SCH and SHyper did not exhibit significantly increased mortality; adjusted hazard ratios (95% CI) of 1.05 (0.74-1.49), p = 0.79 and 0.27 (0.04-1.95), p = 0.19, respectively. CONCLUSIONS: Thyroid dysfunction is common in AMI patients on admission to hospital and our data provide an understanding regarding which factors might influence thyroid dysfunction in these patients. Furthermore, the negative association between LT3S and increased mortality post-AMI has once again been highlighted by this study. More research is required to assess if treatment of thyroid dysfunction improves clinical outcomes.


Asunto(s)
Autoanticuerpos/sangre , Creatinina/sangre , Síndromes del Eutiroideo Enfermo , Hipertiroidismo , Hipotiroidismo , Infarto del Miocardio , Tiroxina/sangre , Causalidad , Correlación de Datos , Inglaterra/epidemiología , Síndromes del Eutiroideo Enfermo/diagnóstico , Síndromes del Eutiroideo Enfermo/epidemiología , Femenino , Humanos , Hipertiroidismo/sangre , Hipertiroidismo/epidemiología , Hipertiroidismo/fisiopatología , Hipotiroidismo/sangre , Hipotiroidismo/epidemiología , Hipotiroidismo/fisiopatología , Masculino , Persona de Mediana Edad , Mortalidad , Infarto del Miocardio/sangre , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/epidemiología , Infarto del Miocardio/fisiopatología , Valor Predictivo de las Pruebas , Prevalencia , Delgadez/diagnóstico , Delgadez/epidemiología
2.
Clin Endocrinol (Oxf) ; 85(6): 949-953, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27291145

RESUMEN

CONTEXT: Neutropenia secondary to antithyroid drug (ATD) therapy in Graves' disease (GD) is well recognized. However, the effect of hyperthyroidism, prior to and after ATD therapy, on neutrophil counts in patients with GD is unclear. OBJECTIVE: To study the prevalence of neutropenia in newly diagnosed untreated GD and the effect of ATD on the neutrophil count. DESIGN: Prospective study from August 2010 to December 2014. SETTING: Endocrinology outpatient clinic in a single centre. PATIENTS: Consecutive patients (n = 206) with newly diagnosed GD. INTERVENTION: ATD therapy. MAIN OUTCOME MEASURES: Prevalence and factors predicting neutropenia (<2 × 109 /l) and change in neutrophil counts following ATD. RESULTS: At diagnosis, 29 (14·1%) of GD individuals had neutropenia. Non-Caucasians [odds ratio (95% CI) of 4·06 (1·14-14·45), P = 0·03] and patients with higher serum thyroid hormone levels [OR 1·07 (1·02-1·13), P = 0·002 for serum FT3] were the only independent predictors of neutropenia. All patients with neutropenia had normalized blood neutrophil levels after achieving euthyroidism with ATD therapy. In patients in whom data were available posteuthyroidism (n = 149), change in neutrophil count after achieving euthyroidism was independently related to reduction in thyroid hormone levels (P < 0·01). CONCLUSIONS: GD is associated with neutropenia in one in seven patients at diagnosis, especially in non-Caucasians and those with higher serum thyroid hormone levels. Neutrophil counts increase with treatment with ATD and are related to reduction in thyroid hormone concentrations. It is therefore important to check neutrophil levels in newly diagnosed patients with GD prior to commencing ATD therapy as otherwise low levels may incorrectly be attributed to ATD therapy.


Asunto(s)
Enfermedad de Graves/complicaciones , Hipertiroidismo/tratamiento farmacológico , Neutropenia/prevención & control , Adulto , Antitiroideos/uso terapéutico , Recuento de Células , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neutrófilos , Estudios Prospectivos , Hormonas Tiroideas/sangre , Triyodotironina/sangre
3.
Osteoporos Int ; 27(3): 1199-1208, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26468040

RESUMEN

SUMMARY: Data on vitamin D status in very old adults are lacking. The aim of this study was to assess 25-hydroxyvitamin D [25(OH)D] concentrations and its predictors in 775 adults aged 85 years old living in North-East England. Low 25(OH)D was alarmingly high during winter/spring months, but its biological significance is unknown. INTRODUCTION: Despite recent concerns about the high prevalence of vitamin D deficiency in much of the British adult and paediatric population, there is a dearth of data on vitamin D status and its predictors in very old adults. The objective of the present study was to describe vitamin D status and its associated factors in a broadly representative sample of very old men and women aged 85 years living in the North East of England (55° N). METHODS: Serum concentrations of 25-hydroxyvitamin D [25(OH)D] were analysed in 775 participants in the baseline phase of the Newcastle 85+ cohort study. Season of blood sampling, dietary, health, lifestyle and anthropometric data were collected and included as potential predictors of vitamin D status in ordinal regression models. RESULTS: Median serum 25(OH)D concentrations were 27, 45, 43 and 33 nmol/L during spring, summer, autumn and winter, respectively. The prevalence of vitamin D deficiency according to North American Institute of Medicine guidelines [serum 25(OH)D <30 nmol/L] varied significantly with season with the highest prevalence observed in spring (51%) and the lowest prevalence observed in autumn (23%; P < 0.001). Reported median (inter-quartile range) dietary intakes of vitamin D were very low at 2.9 (1.2-3.3) µg/day. In multivariate ordinal regression models, non-users of either prescribed or non-prescribed vitamin D preparations and winter and spring blood sampling were associated with lower 25(OH)D concentrations. Dietary vitamin D intake, disability score and disease count were not independently associated with vitamin D status in the cohort. CONCLUSION: There is an alarming high prevalence of vitamin D deficiency (<30 nmol/L) in 85-year-olds living in North East England at all times of the year but particularly during winter and spring. Use of vitamin D containing preparations (both supplements and medications) appeared to be the strongest predictor of 25(OH)D concentrations in these very old adults.


Asunto(s)
Deficiencia de Vitamina D/epidemiología , Vitamina D/análogos & derivados , Anciano de 80 o más Años , Recolección de Muestras de Sangre/métodos , Calcio de la Dieta/administración & dosificación , Dieta/estadística & datos numéricos , Suplementos Dietéticos , Inglaterra/epidemiología , Ejercicio Físico/fisiología , Femenino , Humanos , Estudios Longitudinales , Masculino , Prevalencia , Características de la Residencia , Factores de Riesgo , Estaciones del Año , Vitamina D/administración & dosificación , Vitamina D/sangre , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/etiología
4.
Acta Neurol Scand ; 130(3): 197-203, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24840674

RESUMEN

OBJECTIVES: CADASIL is a monogenic small vessel vasculopathy causing recurrent stroke. Early descriptions suggested dementia and disability were common from the 5th decade but there is evidence of marked phenotypic variability. We investigated the prevalence and clinical features of CADASIL in the west of Scotland. METHODS: We undertook a retrospective review of clinical records of patients with confirmed CADASIL identified through a specialist clinic. Patients were divided to examine the effect of date of diagnosis on clinical outcomes and the characteristics at different ages. The location of pedigree members was used to estimate prevalence. RESULTS: Twenty-one different CADASIL-causing NOTCH3 mutations were identified in 49 pedigrees (61% in exon 4). Disease prevalence in Glasgow was 4.6/100,000 adults. Mutation prevalence was estimated at 10.7/100,000 population. Median age at first stroke in women (57 years) was higher than previous estimates, and stroke age in men was higher in patients diagnosed more recently (pre 2006 46 years, post 2006 56 years, P=0.034). In patients over 58 years of age, 13/34 (38%) were living independently and 17/28 (61%) were mobile without aids when last seen. CONCLUSIONS: CADASIL prevalence is at least 4.6 per 100,000 adults. Median age of first stroke may be older than previously thought. Clinicians should consider CADASIL in the differential diagnosis even in older patients with stroke.


Asunto(s)
CADASIL/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , CADASIL/complicaciones , CADASIL/genética , Exones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutación , Linaje , Prevalencia , Receptor Notch3 , Receptores Notch/genética , Estudios Retrospectivos , Escocia/epidemiología , Accidente Cerebrovascular/etiología
5.
Diabet Med ; 27(6): 696-700, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20546290

RESUMEN

BACKGROUND: An interaction between fusidic acid and HMG coenzyme A reductase inhibitors (statins), resulting in rhabdomyolysis, has been described. Pain and mild weakness are common presenting symptoms. CASE REPORT: We report four patients with Type 2 diabetes prescribed long-term statin treatment who, following treatment with fusidic acid, presented atypically with painless, severe flaccid paralysis suggestive of Guillain-Barré syndrome. This, together with nerve conduction studies consistent with Guillain-Barré syndrome, resulted in the delayed recognition of rhabdomyolysis in these cases. CONCLUSIONS: The addition of fusidic acid can precipitate rhabdomyolysis in patients with diabetes already taking a statin. This can present with rapidly progressive weakness resembling Guillain-Barré syndrome. We recommend that creatine kinase is checked in patients with diabetes on statin therapy who present with profound weakness and routinely in those commenced on prolonged courses of fusidic acid.


Asunto(s)
Antibacterianos/efectos adversos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Nefropatías Diabéticas/tratamiento farmacológico , Ácido Fusídico/efectos adversos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Rabdomiólisis/inducido químicamente , Anciano , Diagnóstico Diferencial , Interacciones Farmacológicas , Femenino , Síndrome de Guillain-Barré/inducido químicamente , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Factores de Tiempo
6.
Diabetologia ; 52(8): 1464-73, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19484217

RESUMEN

AIMS/HYPOTHESIS: Type 1 diabetes is associated with premature arterial disease. Bone-marrow derived, circulating endothelial progenitor cells (EPCs) are believed to contribute to endothelial repair. The hypothesis tested was that circulating EPCs are reduced in young people with type 1 diabetes without vascular injury and that this is associated with impaired endothelial function and increased carotid intima-media thickness (CIMT). METHODS: We compared 74 people with type 1 diabetes with 80 healthy controls. CD34, CD133, vascular endothelial (VE) growth factor receptor-2 (VEGFR-2) and VE-cadherin antibodies were used to quantify EPCs and progenitor cell subtypes using flow-cytometry. Ultrasound assessment of endothelial function by brachial artery flow-mediated dilatation (FMD) and CIMT was made. Circulating endothelial markers, inflammatory markers and plasma plasminogen activator inhibitor-1 (PAI-1) levels were measured. RESULTS: CD34+VE-cadherin+, CD133+VE-cadherin+ and CD133+VEGFR-2+ EPC counts were significantly lower in people with diabetes (46-69%; p = 0.004-0.043). In people with type 1 diabetes, FMD was reduced by 45% (p < 0.001) and CIMT increased by 25% (p < 0.001), these being correlated (r = -0.25, p = 0.033). There was a significant relationship between FMD and CD34+VE-cadherin+ (r = 0.39, p = 0.001), CD133+VEGFR-2+ (r = 0.25, p = 0.037) and CD34+ (r = 0.34, p = 0.003) counts. Circulating high-sensitivity C-reactive protein, PAI-1, interleukin-6 and E-selectin were significantly higher in the diabetes group (p < 0.001 to p = 0.049), the last two of these correlating with FMD (r = -0.27, p = 0.028 and r = -0.24, p = 0.048, respectively). CONCLUSIONS/INTERPRETATION: These findings suggest that abnormalities of endothelial function in addition to pro-inflammatory and pro-thrombotic states are already common in people with type 1 diabetes before development of clinically evident arterial damage. Low EPC counts confirm risk of macrovascular complications and may account for impaired endothelial function and predict future cardiovascular events.


Asunto(s)
Arterias Carótidas/fisiopatología , Diabetes Mellitus Tipo 1/fisiopatología , Células Endoteliales/fisiología , Endotelio Vascular/fisiopatología , Túnica Íntima/fisiopatología , Túnica Media/fisiopatología , Adolescente , Adulto , Velocidad del Flujo Sanguíneo , Glucemia/metabolismo , Presión Sanguínea , Péptido C/sangre , Arterias Carótidas/patología , Arterias Carótidas/fisiología , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/patología , Endotelio Vascular/fisiología , Femenino , Humanos , Masculino , Inhibidor 1 de Activador Plasminogénico/sangre , Valores de Referencia , Túnica Íntima/patología , Túnica Íntima/fisiología , Túnica Media/patología , Túnica Media/fisiología , Receptor 2 de Factores de Crecimiento Endotelial Vascular/inmunología , Receptor 2 de Factores de Crecimiento Endotelial Vascular/fisiología , Vasodilatación , Adulto Joven
7.
Eur J Neurol ; 13(11): 1261-3, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17038043

RESUMEN

A 43-year-old lady presented with bilateral foot drop due to alcohol-related peripheral neuropathy. There was no history of electrolyte disturbance or altered consciousness. Cranial nerve, bulbar and pyramidal symptoms and signs were absent. Nerve conduction studies confirmed the neuropathy. Inadvertently requested neuroimaging of brain demonstrated signal change typical of central pontine myelinolysis. Asymptomatic pontine myelinolysis occurs rarely in alcoholics in the absence of bulbar dysfunction. It is important for physicians to be aware of the clinical entity of asymptomatic pontine myelinolysis to avoid misinterpretation of abnormalities detected on cerebral imaging in alcoholic individuals.


Asunto(s)
Alcoholismo/complicaciones , Mielinólisis Pontino Central/complicaciones , Mielinólisis Pontino Central/fisiopatología , Adulto , Femenino , Trastornos Neurológicos de la Marcha/etiología , Humanos , Hallazgos Incidentales , Imagen por Resonancia Magnética , Mielinólisis Pontino Central/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología
8.
Am J Cardiol ; 70(3): 379-84, 1992 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-1632407

RESUMEN

Previous investigators have demonstrated that B-mode ultrasonography can provide high resolution images of the carotid arteries. When combined with Doppler flow measurements, quantitative estimates of luminal narrowing may also be obtained. B-mode imaging is limited, however, in its ability to provide a composite view of the vessel wall, lumen and plaque. Spatial relations between structures visualized in individual frames must be inferred from repeated transducer passes over the designated site, or repeated review of recorded images, followed by a "mind's eye" reconstruction. Three-dimensional (3-D) reconstruction of serially recorded cross-sectional images from current B-mode systems represents a possible solution to this limited spatial display that preserves detail regarding vessel wall pathology. Accordingly, computer-based automated 3-D reconstruction was used to generate a tangible format with which to assess and compare serially and transcutaneously recorded 2-dimensional (2-D) B-mode images of the carotid arteries. One or more timed sweep recordings of the 2-D B-mode examination were obtained from 5 patients for 3-D reconstruction. In all cases, satisfactory 3-D reconstruction was accomplished in three 3-D formats: cylindrical, sagittal and lumen cast. Sagittal 3-D reconstruction provided information regarding pathologic alterations within the arterial wall. Experience with the cylindrical mode suggests that this 3-D format, particularly when the reconstructed vascular segment is hemisected, is optimally suited for those cases in which direct inspection of luminal topography is of special interest. The lumen cast display, used with a recently validated edge-detection algorithm, may enhance the use of B-mode ultrasound for assessment of luminal cross-sectional area.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Arterias Carótidas/diagnóstico por imagen , Procesamiento de Imagen Asistido por Computador , Adulto , Anciano , Enfermedades de las Arterias Carótidas/diagnóstico por imagen , Femenino , Humanos , Masculino , Ultrasonografía
9.
Surgery ; 97(5): 613-7, 1985 May.
Artículo en Inglés | MEDLINE | ID: mdl-3992484

RESUMEN

Presented is a patient with a tumor containing elements from two germ layers. It was associated within the patient's thyroid gland (located in a benign adenoma), but since the elements were widely separated from each other the tumor could not be classified as a teratoma or hamartoma. To our knowledge no similar tumor has been described. The interesting characteristics of this patient are described. The characteristics of this benign tumor are compared with those of cases in the literature of adult thyroid teratomas.


Asunto(s)
Teratoma/patología , Neoplasias de la Tiroides/patología , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Teratoma/cirugía , Neoplasias de la Tiroides/cirugía
10.
Arch Surg ; 114(7): 857-9, 1979 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-222233

RESUMEN

We report a 12th case in which infection of the colon with cytomegalovirus was demonstrated in association with ulcerative collitis. Rectal biopsy has proven to be reliable in identifying cells with cytomegaloviral inclusion bodies if careful histologic evaluation is performed. Thus far, prognosis has been serious when cytomegalovirus of the colon has been documented in ulcerative colitis. Nine of 12 patients have required a colectomy, and only seven of 12 have survived.


Asunto(s)
Colitis Ulcerosa/complicaciones , Infecciones por Citomegalovirus/complicaciones , Agammaglobulinemia/complicaciones , Colectomía , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/patología , Infecciones por Citomegalovirus/inmunología , Infecciones por Citomegalovirus/patología , Femenino , Humanos , Ileostomía , Leucopenia/complicaciones , Persona de Mediana Edad , Trombocitopenia/complicaciones
11.
Arch Surg ; 120(11): 1321-2, 1985 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-3931611

RESUMEN

Five patients receiving penicillin V potassium or a cephalosporin antibiotic for 18 hours to 22 days developed fever, marked leukocytosis, and signs and symptoms that suggested right-lower-quadrant peritoneal irritation. All underwent emergency laparotomy, at which dilatation and inflammation of the ascending colon were found. Only one of the patients had profuse diarrhea, and two patients had no diarrhea prior to laparotomy. Postoperatively, Clostridium difficile colitis was diagnosed by stool toxin assay and was confirmed in one case by proctosigmoidoscopic biopsy results. Antibiotic-associated colitis must be considered in any patient who develops peritoneal signs while or after receiving antibiotics. Over a two-year period, the "acute abdomen" presentation accounted for 5.2% of all patients with C difficile colitis at our institutions. Early proctosigmoidoscopy or stool examination for C difficile or its toxin may avoid unnecessary laparotomy in such patients.


Asunto(s)
Infecciones por Clostridium/diagnóstico , Colitis/diagnóstico , Peritonitis/diagnóstico , Enfermedad Aguda , Adulto , Anciano , Cefalosporinas/efectos adversos , Infecciones por Clostridium/inducido químicamente , Colitis/inducido químicamente , Diagnóstico Diferencial , Femenino , Humanos , Penicilina V/efectos adversos
12.
Thyroid ; 14(11): 916-25, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15671770

RESUMEN

INTRODUCTION: This paper reports work undertaken to design two new condition-specific questionnaires for use in hypothyroidism: the Underactive Thyroid-Dependent Quality of Life Questionnaire (ThyDQoL) and the Underactive Thyroid Treatment Satisfaction Questionnaire (ThyTSQ). METHODS: Semistructured interviews exploring quality of life (QoL) and experiences of treatment were conducted with 30 women and 8 men with hypothyroidism, (mean age, 51.9; range, 29-79 years), 37 of 38 treated with thyroxine, recruited from hospital clinics and primary care. RESULTS: Despite thyroxine treatment, most interviewees reported negative impact of hypothyroidism on QoL, particularly on energy, physical capabilities, motivation, physical appearance, and weight. The newly designed ThyDQoL has 18 domains covering these and other aspects of life affected by hypothyroidism. It is an individualized measure of patients' perceived impact of hypothyroidism on their QOL, which takes into account the importance of personally applicable life domains to the patient. A 7-item measure of satisfaction with current treatment was designed (ThyTSQ-Present) but interviews also indicated the need for a separate 4-item section measuring satisfaction with past treatment around the time of diagnosis (ThyTSQPast). CONCLUSIONS: The ThyDQoL and ThyTSQ questionnaires have good face validity and content validity for adults with hypothyroidism. They are now ready for use in clinical research and psychometric evaluation.


Asunto(s)
Hipotiroidismo/fisiopatología , Hipotiroidismo/psicología , Satisfacción del Paciente , Calidad de Vida , Encuestas y Cuestionarios , Adulto , Anciano , Femenino , Humanos , Hipotiroidismo/tratamiento farmacológico , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios/normas , Tiroxina/uso terapéutico
13.
Seizure ; 12(5): 295-9, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12810342

RESUMEN

OBJECTIVE: To assess the role of head up tilt testing (HUT) in diagnosing probable or possible vasovagal syncope (VVS) in patients referred from an epilepsy clinic. METHODS: One hundred thirty two patients underwent HUT over 36 months. Complete data were available on 128 patients (52 male) aged 14-80 (mean 36.7) years. The main indication for HUT (head up tilt at 70 degrees for 45 minutes) was recurrent undiagnosed blackouts, likely to be VVS. Patients were divided, prior to knowledge of the HUT results, into probable VVS, possible VVS, or probable/possible VVS associated with definite epilepsy. RESULTS: HUT was positive in 72 patients (56%), and led to an alternative definite diagnosis in 31 (24%). Diagnostic change was more likely in those provisionally labelled either as possible VVS (15 of 34; 44%) or as a combination of epilepsy with possible or probable VVS (12 of 19; 63%) compared to those with probable VVS (4 of 75; 5%; P<0.01).Of the 45 patients previously treated with antiepileptic medications 27 did not have epilepsy. CONCLUSION: HUT has an important role in confirming or refuting the diagnosis of VVS in patients presenting with undiagnosed blackouts to an epilepsy clinic, and particularly so in patients with possible rather than probable VVS, and in those thought to have a combination of epilepsy and possible or probable VVS.


Asunto(s)
Epilepsia/diagnóstico , Síncope Vasovagal/diagnóstico , Pruebas de Mesa Inclinada , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anticonvulsivantes/uso terapéutico , Comorbilidad , Diagnóstico Diferencial , Epilepsia/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Probabilidad , Sensibilidad y Especificidad
14.
Acta Anaesthesiol Belg ; 40(1): 41-51, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2499160

RESUMEN

Recovery from anesthesia and the effect of premedication, induction agent and the individual anesthetist on the measure of recovery was assessed in 707 patients scheduled to undergo short surgical procedures. Patients were randomly allocated to receive either alfentanil or enflurane as a supplement to an induction agent, nitrous oxide/oxygen anesthetic technique with or without premedication. Patients who received alfentanil had a faster immediate recovery than those who received enflurane (p less than 0.001). Total anesthetic time was shorter in the alfentanil group (p = 0.02). For 36 of 37 anesthetists recovery was faster in the alfentanil group compared to the enflurane group. Choice of premedication and induction agent had a significant effect on recovery, thiopentone or lorazepam prolonged recovery time in each group. Although the alfentanil group had a higher incidence of apnoea, movement and vomiting (p less than 0.001), the enflurane group had a higher incidence of coughing (p less than 0.001) and shivering (p = 0.004). Overall the anesthetists assessed the alfentanil technique as excellent or good in more patients than the enflurane technique.


Asunto(s)
Anestésicos/farmacología , Enflurano/farmacología , Fentanilo/análogos & derivados , Adyuvantes Anestésicos/farmacología , Adolescente , Adulto , Anciano , Alfentanilo , Periodo de Recuperación de la Anestesia , Femenino , Fentanilo/farmacología , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Menores , Estudios Multicéntricos como Asunto , Medicación Preanestésica
15.
Clin Obes ; 2(1-2): 25-8, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25586044

RESUMEN

Obesity is positively associated with serum thyrotropin (TSH) concentrations at the high end of the normal range. The relationship between weight loss and thyroid function is less clear and studies to date have yielded inconsistent results. Our aim was to describe changes in thyroid function in obese people in relation to durable and significant weight loss after Roux-en-Y gastric bypass (RYGB) surgery. We recorded percentage of excess weight loss (% EWL), serum TSH and free thyroxine (fT4) before and median 4.5, 15 and 24 months after RYGB in 55 euthyroid patients with morbid obesity ranging in age from 18 to 64 years in a retrospective cohort analysis in a university hospital in Greater Manchester. Mean ± standard error preoperative weight was 135.13 ± 4.23 kg and BMI 48.08 ± 1.58 kg m(-2) . Patients attained nadir %EWL of 68% by median 15 months after RYGB. TSH was 2.00 ± 0.14 mU L(-1) at baseline and 2.02 ± 0.22 mU L(-1) at 24 months after RYGB (non-significant). Baseline fT4 was 13.46 ± 0.28 pmol L(-1) , and increased significantly to 15.14 ± 0.55 pmol L(-1) at 24 months (P < 0.004). In conclusion, we report that weight loss after RYGB was accompanied by significant increase in serum fT4 but no change in TSH concentrations. Further study to elucidate the effect of significant weight loss on the thyroid axis is required.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA